Ontology highlight
ABSTRACT: Background
Treatment of refractory ascites in liver cirrhosis is challenging. Transjugular intrahepatic portosystemic shunt and alfapump® have been proposed for the management, but few data comparing both exist.Aims
The aim of this study was to evaluate the characteristics and outcomes of patients treated with transjugular intrahepatic portosystemic shunt and alfapump® for refractory ascites at our centre.Methods
All consecutive patients were retrospectively reviewed for baseline characteristics, efficacy of treatment, complications and survival.Results
In total, 19 patients with transjugular intrahepatic portosystemic shunt and 40 patients with alfapump® were included. Patients with transjugular intrahepatic portosystemic shunt had better liver function and
SUBMITTER: Will V
PROVIDER: S-EPMC7707873 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature